drugset / Trial / NCT01476774

NORSPAN Transdermal Patches Phase III Study In Non-Cancer Pain

NCT01476774

Phase 3 Completed 280 enrolled Mundipharma (China) Pharmaceutical Co. Ltd
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This is a multiple-dose, double-blind, double-dummy, active-control, parallel-group, multi-center, safety and efficacy study.

Timeline

Start
2009-08
Primary completion
2010-06
Completion

Drugs

EvaluationDrugModalityDoseRoute
Comparator Buprenorphine Other / unclassified 5 ug Other
Comparator Buprenorphine Other / unclassified 10 ug Other
Comparator Buprenorphine Other / unclassified 20 ug Other
Subject Tramadol Other / unclassified 100 mg Oral
Subject Tramadol Other / unclassified 200 mg Oral